tiprankstipranks
Claritas Pharmaceuticals (CLAZF)
OTHER OTC:CLAZF
US Market
CLAZF
Claritas Pharmaceuticals
RESEARCH TOOLSreports
Want to see CLAZF full AI Analyst Report?

Claritas Pharmaceuticals (CLAZF) Income Statement

24 Followers

Claritas Pharmaceuticals Income Statement

Last quarter (Q3 2021), Claritas Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Claritas Pharmaceuticals's net income was $181.00K. See Claritas Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 20Sep 20Mar 19Dec 17
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ -184.00K$ 9.45M$ 11.10M$ 5.09M
Depreciation and Amortization
$ -184.00K$ 9.45M$ 11.10M$ 19.00K
EBITDA
$ -2.79M$ -16.72M$ 18.14M$ -15.44M
Operating Income
$ -3.28M$ -9.45M$ -11.10M$ -14.50M
Other Income/Expenses
$ 3.25M$ -16.13M$ 17.94M$ -17.36M
Pretax Income
$ -674.00K$ -25.83M$ 6.84M$ -31.86M
Net Income
$ 4.21M$ -21.21M$ 6.93M$ -31.86M
Per Share Metrics
Basic EPS
$ 0.16$ -0.95$ 0.55$ -5.20
Diluted EPS
$ 0.16$ -1.00$ 0.64$ -5.20
Weighted Average Shares Outstanding
 26.69M 22.44M 12.52M 6.21M
Weighted Average Shares Outstanding (Diluted)
 26.69M 22.44M 10.92M 6.21M
Currency in USD

Claritas Pharmaceuticals Earnings and Revenue History